Duarte RRR, Copertino DC, Iñiguez LP, Marston JL, Bram Y, Han Y, Schwartz RE, Chen S, Nixon DF, Powell TR.  2021.  Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry.. Mol Med. 27(1):105.

Draper MW.  2006.  An update on raloxifene.. Int J Gynecol Cancer. 16 Suppl 2:502-3.

Wijayaratne AL, Nagel SC, Paige LA, Christensen DJ, Norris JD, Fowlkes DM, McDonnell DP.  1999.  Comparative analyses of mechanistic differences among antiestrogens.. Endocrinology. 140(12):5828-40.